Sinphar Pharmaceutical Co. Ltd. - Taiwan
Figures in New Taiwan dollars.
2026 2025
Revenue NT$300,796,000 NT$272,611,000
Jan-May Revenue NT$1,418,493,000 NT$1,349,318,000
Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.